Kiniksa CEO Sanj K Patel sells shares worth $2.62 million
PUBT · 05/01 20:33
Share
Listen to the news
- Kiniksa Pharmaceuticals Chairman and CEO Sanj K. Patel sold 48,565 Class A ordinary shares on May 1, 2026 at a weighted average price of $54.02.
- Patel reported acquiring 48,565 Class A ordinary shares via option exercise at $30.93, then disposing of the same amount, leaving 0 shares held directly.
- Indirect holdings totaled 237,763 Class A ordinary shares through family trusts.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kiniksa Pharmaceuticals International plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001532218-26-000008), on May 01, 2026, and is solely responsible for the information contained therein.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.
Copyright © 2026 Webull. All Rights Reserved